Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Universiteit Antwerpen
Belgian Government
Information provided by (Responsible Party):
M Claeys, Universiteit Antwerpen Identifier:
First received: July 29, 2008
Last updated: August 7, 2016
Last verified: August 2016
The purpose of this observational study is to assess predictors of in-hospital mortality in patients with acute myocardial infarction admitted to Belgian hospitals.

Acute Myocardial Infarction

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Observational Study to Assess Predictors of in Hospital Mortality in STEMI Patients Admitted in Belgian Hospitals

Resource links provided by NLM:

Further study details as provided by Universiteit Antwerpen:

Primary Outcome Measures:
  • all cause mortality [ Time Frame: one month ] [ Designated as safety issue: No ]

Estimated Enrollment: 5000
Study Start Date: July 2007
Estimated Study Completion Date: December 2018
Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients with acute ST elevation myocardial infarction admitted in Belgian hospitals.

Inclusion Criteria:

  • clinical diagnosis of acute myocardial infarction with ST elevation or left bundle branch blok pattern on ECG

Exclusion Criteria:

  • acute myocardial infarction as an acute complication of coronary intervention
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00727623

Contact: Marc J Claeys, MD PhD 3238214706
Contact: Christiaan M Vrints, MD PhD 3238214720

Centre Hospitalier de Jolimont Recruiting
La Louviere, Hainaut, Belgium, 7100
Contact: Antoine de Meester, MD    32 64 233011   
Sponsors and Collaborators
Universiteit Antwerpen
Belgian Government
Principal Investigator: Marc J Claeys, MD.PhD University Hospital, Antwerp
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: M Claeys, Prof dr, Universiteit Antwerpen Identifier: NCT00727623     History of Changes
Other Study ID Numbers: BIWAC-01 
Study First Received: July 29, 2008
Last Updated: August 7, 2016
Health Authority: Belgium: Ministry of Social Affairs, Public Health and the Environment

Keywords provided by Universiteit Antwerpen:
acute coronary syndrome
myocardial infarction
predictors of mortality
reperfusion therapy

Additional relevant MeSH terms:
Myocardial Infarction
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases processed this record on October 21, 2016